References
1. Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring.
Best Pract Res Clin Obstet Gynaecol. 2008;22:801-823
2. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol. 2000;24:11-14.
3. Pilas-Pomykalska M, Czajkowskii J, Oszukowski P (2005) [Ocular changes during pregnancy]. Ginekol Pol 76(8): 655-660.
4. Jadotte YT, Schwartz RA. Melasma: insights and perspectives. Acta
Dermatovenerol Croat. 2010;18:124-129
5. Schlehter JE, Pidgeon M, Chang D, Fong YC, Trousdale MD, Chang N. Potential role of disrupted lacrimal acinar cells in dry eye during pregnancy. Adv Exp Med Biol. 2002;506:153-157.
6. Weinreb RN, Lu A, Beeson C (1988) Maternal corneal thickness during pregnancy. Am J Ophthalmol 105(3): 258-260.
7. Park SB, Lindahl KJ, Temnycky GO, Aquavella JV (1992) The effect of
pregnancy on corneal curvature. CLAO J 18(4): 256-269.
8. Fatt I, Harris MG (1973) Refractive index of the cornea as a function of its thickness. Am J Optom Arch Am Acad Optom 50(5): 383-386.
9. Samra KA (2013) The eye and visual system in pregnancy, what to expect? An in-depth review. Oman J Ophthalmol 6(2): 87-91.
10. Sunness JS (1988) The pregnant woman’s eye. Surv Ophthalmol 32(4): 219-238.
11. Akar Y, Yucel I, Akar ME, Zorlu G, Ari ES (2005) Effect of pregnancy on intraobserver and intertechnique agree-ment in intraocular pressure measure-ments. Ophthalmologica 219(1): 36-42.
12. Sen E, Onaran Y, Nalcacioglu-Yuksek-kaya P, Elgin U, Ozturk F (2014) Corneal biomechanical parameters during pregna-ncy. Eur J Ophthalmol 24(3): 314-319.
13. Ebeigbe JA, Ebeigbe PN, Ighoroje A (2012) Ocular changes in pregnant Nigerian women. Niger J Clin Pract 15(3): 298-301.
14. Ali S, Dornhorst A (2011) Diabetes in pregnancy: health risks and management. Postgrad Med J 87(1028): 417-427.
15. Sheth BP (2008) Does pregnancy accelerate the rate of progression of diabetic retinopathy? an update. Curr Diab Rep 8(4): 270-273.
16. (1979) The Diabetic Retinopathy Study Research Group, Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. Arch Ophthalmol 97(4): 654-655.
17. Horvat M, Maclean H, Goldberg L, Crock GW (1980) Diabetic retinopathy in pregnancy: a 12-year prospective survey. Br J Ophthalmol 64(6): 398-403.
18. Qureshi IA, Xi XR, Wu XD (1996) Intraocular pressure trends in pregnancy and in the third trimester hypertensive patients. Acta Obstet Gynecol Scand 75(9): 816-819.
19. Efe YK, Ugurbas SC, Alpay A, Ugurbas SH (2012) The course of cornealand intraocular pressure changes during pregnancy. Can J Ophthalmol 47(2): 150-154.
20. Molitch ME (2003) Pituitary tumors and pregnancy. Growth Horm IGF Res 13 Suppl A: S38-S44.
21. Imran SA, Ur E, Clarke DB (2007) Managing prolactin-secreting adenomas during pregnancy. Can Fam Physician 53(4): 653-658.
22. Wan WL, Geller JL, Feldon SE, Sadun AA (1990) Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophthalmology 97(1): 18-21.
23. Kanaan I, Jallu A, Kanaan H (2003) Management Strategy for Meningioma in Pregnancy: A Clinical Study. Skull Base 13(4): 197-203.
24. Kump LI, Cervantes-Castañeda RA, Androudi SN, Foster CS, Christen WG (2006) Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm 14(2): 99-104.
25. Mor G, Cardenas I, Abrahams V, Guller S (2011) Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 1221: 80-87.
26. Bonfioli AA, Orefice F (2005) Toxoplas-mosis. Semin Ophthalmol 20(3): 129-141.
27. Chung CY, Kwok AK (2004) Chung KL Use of ophthalmic medications during pregnancy. Hong Kong Med J 10(3): 191-195
28. Sunness JS, Haller JA, Fine SL (1993) Central serous chorioretinopathy and pregnancy. Arch Ophthalmol 111(3): 360-364
29. Patchett RB, Wilson WB, Ellis PP. Ophthalmic complications with dissemi-nated intravascular coagulation. Br J Ophthalmol. 1988;72:377-379.
30. Hoines J, Buettner H. Ocular complicat-ions of disseminated intravascular coagulation (DIC) in abruptio placentae. Retina. 1989;9:105-109.
31. Montagnana M, Franchi M, Danese E, Gotsch F, Guidi GC. Disseminated
intravascular coagulation in obstetric and gynecologic disorders. Semin Thromb Hemost. 2010;36:404-418.
32. Yılmaz A, Pata Ö, Öz Ö, Yıldırım Ö, Dilek S. Preeklampside iki taraflı seröz retina dekolmanı. Ret-Vit. 2005;13:307-310.
33. Taşkapili M, Kocabora S, Gülkilik G. Unusual ocular complications of
the HELLP syndrome:persistent macular elevationand localized tractional retinal detachment. Ann Ophthalmol. (Skokie) 2007;39:261-263.
34. Gültan E. Gebelikte karşılaşılan göz hastalıkları. Tıbbi Retina. Türk
Oftalmoloji Derneği Eğitim Yayınları. 2009;10:211-218.
35. Percival SP. Ocular findings in thrombotic thrombocytopenic purpura (Moschcowitz’s disease). Br J Ophthalmol. 1970;54:73-78.
36. Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody
syndrome (APS)-current concepts. Surv Ophthalmol. 2002;47:215-238.
37. Tsironi E, Gatselis N, Kotoula MG, Zachou K, Pefkianaki M, Zacharaki
F, Chatzoulis DZ, Dalekos GN. Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series. Cases J. 2009;2:159.
DOI: https://dx.doi.org/10.18535/jmscr/v5i7.17
